STOCK TITAN

[Form 4] LivaNova PLC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

LivaNova PLC (LIVN) director Donald Zurbay was granted 2,560 Restricted Stock Units (RSUs) on September 15, 2025. Each RSU converts to one ordinary share under the LivaNova PLC 2025 Director Incentive Award Plan. The grant carries vesting and forfeiture restrictions that are scheduled to lapse on June 15, 2026, subject to continued service and the award agreement. The reported RSUs have a $0 per-unit reported grant price on the Form 4 and are shown as directly beneficially owned following the award. The Form 4 was signed on behalf of the reporting person by an Attorney-in-Fact on September 17, 2025.

Il direttore di LivaNova PLC (LIVN), Donald Zurbay, ha ricevuto il 15 settembre 2025 2.560 RSU (Restricted Stock Units). Ogni RSU si convertirà in una azione ordinaria ai sensi del Piano 2025 Director Incentive Award di LivaNova PLC. L’assegnazione è soggetta a restrizioni di vesting e di perdita che, a condizione di un proseguimento del servizio e secondo l’accordo sull’assegnazione, dovrebbero decadere il 15 giugno 2026. Le RSU riportate hanno un prezzo di assegnazione per unità di $0 nel Form 4 e sono indicate come proprietà direttamente beneficiaria a seguito dell’assegnazione. Il Form 4 è stato firmato per conto della persona che segnala da un Procuratore in carica il 17 settembre 2025.

El director de LivaNova PLC (LIVN), Donald Zurbay, recibió el 15 de septiembre de 2025 2.560 RSU (Restricted Stock Units). Cada RSU se convertirá en una acción ordinaria conforme al Plan de Incentivo de Director 2025 de LivaNova PLC. La adjudicación tiene restricciones de vesting y pérdida que, sujeto a la continuación del servicio y al acuerdo de adjudicación, deben caducar el 15 de junio de 2026. Las RSU reportadas tienen un precio de adjudicación por unidad de $0 en el Formulario 4 y se muestran como propiedad directamente beneficiaria tras la adjudicación. El Formulario 4 fue firmado en nombre de la persona reportante por un Procurador en fecha 17 de septiembre de 2025.

LivaNova PLC(LIVN)의 이사인 Donald Zurbay는 2025년 9월 15일에 2,560개 RSU(제한주식단위)를 부여받았습니다. 각 RSU는 LivaNova PLC의 2025년 이사 인센티브 보상 계획에 따라 보통주 한 주로 전환됩니다. 이 부여는 서비스 지속과 계약 조항에 따라 만료될 예정인 보 vesting 및 몰수 제한이 있으며, 이는 2026년 6월 15일에 만료될 예정입니다. 보고된 RSU는 Form 4에서 주당 가격 $0으로 표시되며 부여 직후 직접 유리한 소유로 나타납니다. Form 4는 보고인 대리인의 이름으로 서명되었으며 2025년 9월 17일에 서명되었습니다.

Le administrateur de LivaNova PLC (LIVN), Donald Zurbay, a reçu le 15 septembre 2025 2 560 RSU (Restricted Stock Units). Chaque RSU sera converti en une action ordinaire conformément au Plan 2025 d’attribution d’incitation pour administrateurs de LivaNova PLC. L’octroi est soumis à des restrictions d’acquisition et de perte qui, sous réserve de la poursuite du service et de l’accord relatif à l’octroi, devraient expirer le 15 juin 2026. Les RSU déclarées affichent un prix d’attribution de $0 par unité sur le Formulaire 4 et sont indiquées comme propriété directement bénéficiaire après l’attribution. Le Formulaire 4 a été signé au nom de la personne déclarant par un mandataire le 17 septembre 2025.

Der Direktor von LivaNova PLC (LIVN), Donald Zurbay, erhielt am 15. September 2025 2.560 RSU (Restricted Stock Units). Jede RSU wandelt sich gemäß dem 2025 Director Incentive Award Plan von LivaNova PLC in eineordentliche Aktie um. Die Zuweisung ist mit Vesting- und Verlustbeschränkungen verbunden, die gemäß der Weiterführung des Dienstverhältnisses und der Vereinbarung über die Zuweisung zum 15. Juni 2026 verfallen sollen. Die gemeldeten RSU weisen einen Ausgabepreis von $0 pro Einheit im Formular 4 auf und werden nach der Zuweisung als direkt vorteilhaftes Eigentum ausgewiesen. Das Formular 4 wurde im Namen der meldepflichtigen Person durch einen Bevollmächtigten am 17. September 2025 unterzeichnet.

قام مدير شركة LivaNova PLC (LIVN)، دونالد زورباي، بمنحه في 15 سبتمبر 2025 2,560 وحدة أسهم مقيدة (RSU). كل RSU تتحول إلى سهم عادي وفقاً لـ خطة جائزة حافز المدراء لعام 2025 من LivaNova PLC. يتضمن المنحة قيود الاستحقاق والفقدان التي من المفترض أن تتلاشى في 15 يونيو 2026، رهناً باستمرار الخدمة وفقاً لاتفاق المنحة. تُظهر RSU المعلنة سعر منحة قدره $0 لكل وحدة في النموذج 4 وتُشار إليها باعتبارها ملكاً مباشراً مستفيداً عقب المنحة. تم توقيع النموذج 4 نيابة عن الشخص المبلغ من قبـل وكيل في 17 سبتمبر 2025.

LivaNova PLC(LIVN)董事 Donald Zurbay 于 2025年9月15日 获得了 2,560 个受限股票单位(RSU)。每个 RSU 将按照 LivaNova PLC 2025 年董事激励奖励计划转换为一股普通股。该授予附有归属和没收限制,若继续任职并按授予协议执行,预计在 2026年6月15日 到期失效。所报 RSU 在 Form 4 中的单位授予价格为 $0,并在授予后显示为 直接受益所有权。Form 4 由报送人代理人于 2025年9月17日 代表签署。

Positive
  • Grant disclosed: Reporting person was granted 2,560 RSUs on 09/15/2025 under the 2025 Director Incentive Award Plan
  • Alignment of interests: RSUs vest on 06/15/2026, creating a time‑based link between director service and share ownership
Negative
  • None.

Insights

TL;DR: A routine director equity grant: modest size, time‑based vesting aligns director incentives with shareholders.

The Form 4 discloses a standard director compensation event: 2,560 RSUs awarded to Director Donald Zurbay under the 2025 Director Incentive Award Plan, vesting on June 15, 2026 subject to continued service. Such awards are common governance practice to align board members with long‑term shareholder value. The filing reports direct beneficial ownership post‑grant and shows a $0 reported price per unit, consistent with RSU accounting where shares are delivered upon vesting rather than purchased. This disclosure is procedurally important for transparency but appears non‑material in isolation for company valuation.

TL;DR: Filing meets Section 16 reporting requirements for an insider equity award; timing and signature present required details.

The Form 4 contains required elements: reporting person identity and address, relationship to issuer (Director), transaction date (09/15/2025), instrument type (RSUs), number granted (2,560), vesting/forfeiture date (06/15/2026), and signature by an Attorney‑in‑Fact on 09/17/2025. The entry lists the ownership form as Direct. From a compliance perspective, the disclosure is complete and consistent with standard insider reporting for time‑based RSU grants.

Il direttore di LivaNova PLC (LIVN), Donald Zurbay, ha ricevuto il 15 settembre 2025 2.560 RSU (Restricted Stock Units). Ogni RSU si convertirà in una azione ordinaria ai sensi del Piano 2025 Director Incentive Award di LivaNova PLC. L’assegnazione è soggetta a restrizioni di vesting e di perdita che, a condizione di un proseguimento del servizio e secondo l’accordo sull’assegnazione, dovrebbero decadere il 15 giugno 2026. Le RSU riportate hanno un prezzo di assegnazione per unità di $0 nel Form 4 e sono indicate come proprietà direttamente beneficiaria a seguito dell’assegnazione. Il Form 4 è stato firmato per conto della persona che segnala da un Procuratore in carica il 17 settembre 2025.

El director de LivaNova PLC (LIVN), Donald Zurbay, recibió el 15 de septiembre de 2025 2.560 RSU (Restricted Stock Units). Cada RSU se convertirá en una acción ordinaria conforme al Plan de Incentivo de Director 2025 de LivaNova PLC. La adjudicación tiene restricciones de vesting y pérdida que, sujeto a la continuación del servicio y al acuerdo de adjudicación, deben caducar el 15 de junio de 2026. Las RSU reportadas tienen un precio de adjudicación por unidad de $0 en el Formulario 4 y se muestran como propiedad directamente beneficiaria tras la adjudicación. El Formulario 4 fue firmado en nombre de la persona reportante por un Procurador en fecha 17 de septiembre de 2025.

LivaNova PLC(LIVN)의 이사인 Donald Zurbay는 2025년 9월 15일에 2,560개 RSU(제한주식단위)를 부여받았습니다. 각 RSU는 LivaNova PLC의 2025년 이사 인센티브 보상 계획에 따라 보통주 한 주로 전환됩니다. 이 부여는 서비스 지속과 계약 조항에 따라 만료될 예정인 보 vesting 및 몰수 제한이 있으며, 이는 2026년 6월 15일에 만료될 예정입니다. 보고된 RSU는 Form 4에서 주당 가격 $0으로 표시되며 부여 직후 직접 유리한 소유로 나타납니다. Form 4는 보고인 대리인의 이름으로 서명되었으며 2025년 9월 17일에 서명되었습니다.

Le administrateur de LivaNova PLC (LIVN), Donald Zurbay, a reçu le 15 septembre 2025 2 560 RSU (Restricted Stock Units). Chaque RSU sera converti en une action ordinaire conformément au Plan 2025 d’attribution d’incitation pour administrateurs de LivaNova PLC. L’octroi est soumis à des restrictions d’acquisition et de perte qui, sous réserve de la poursuite du service et de l’accord relatif à l’octroi, devraient expirer le 15 juin 2026. Les RSU déclarées affichent un prix d’attribution de $0 par unité sur le Formulaire 4 et sont indiquées comme propriété directement bénéficiaire après l’attribution. Le Formulaire 4 a été signé au nom de la personne déclarant par un mandataire le 17 septembre 2025.

Der Direktor von LivaNova PLC (LIVN), Donald Zurbay, erhielt am 15. September 2025 2.560 RSU (Restricted Stock Units). Jede RSU wandelt sich gemäß dem 2025 Director Incentive Award Plan von LivaNova PLC in eineordentliche Aktie um. Die Zuweisung ist mit Vesting- und Verlustbeschränkungen verbunden, die gemäß der Weiterführung des Dienstverhältnisses und der Vereinbarung über die Zuweisung zum 15. Juni 2026 verfallen sollen. Die gemeldeten RSU weisen einen Ausgabepreis von $0 pro Einheit im Formular 4 auf und werden nach der Zuweisung als direkt vorteilhaftes Eigentum ausgewiesen. Das Formular 4 wurde im Namen der meldepflichtigen Person durch einen Bevollmächtigten am 17. September 2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Zurbay Donald

(Last) (First) (Middle)
20 EASTBOURNE TERRACE

(Street)
LONDON X0 W2 6LG

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
LivaNova PLC [ LIVN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0(1) 09/15/2025 A 2,560 (2) (2) Ordinary Shares 2,560 $0 2,560 D
Explanation of Responses:
1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one ordinary share of the Company, GBP 1.00 par value, in accordance with the terms of the LivaNova PLC 2025 Director Incentive Award Plan (the "Plan") and the award agreement.
2. On September 15, 2025, reporting person was granted RSUs to vest and forfeiture restrictions thereon to lapse on June 15, 2026, subject to continued service during the vesting period and the award agreement.
Remarks:
/s/ Sarah K. Mohr, Attorney-in-Fact 09/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did LivaNova director Donald Zurbay report on Form 4 (LIVN)?

The Form 4 reports a grant of 2,560 Restricted Stock Units (RSUs) to Donald Zurbay on 09/15/2025.

When do the RSUs granted to the director vest?

The RSUs are scheduled to vest and forfeiture restrictions lapse on 06/15/2026, subject to continued service and the award agreement.

Under which plan were the RSUs granted?

The award was made under the LivaNova PLC 2025 Director Incentive Award Plan as stated in the Form 4.

How many ordinary shares will the RSUs convert into?

Each RSU represents a contingent right to one ordinary share, so the 2,560 RSUs correspond to 2,560 ordinary shares upon vesting.

What price was reported for the RSU grant on the Form 4?

The Form 4 reports a $0 per‑unit price for the RSU award, reflecting that RSUs are granted rather than purchased.
Livanova Plc

NASDAQ:LIVN

LIVN Rankings

LIVN Latest News

LIVN Latest SEC Filings

LIVN Stock Data

2.92B
54.39M
0.38%
103.73%
3.63%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United Kingdom
LONDON